Overview
Key stats
Fundamentals Sep 10- Open
- $66.32
- 52-wk high
- $89.64
- High
- $67.00
- 52-wk low
- $58.72
- Low
- $65.03
- Prev close
- $66.78
- Mkt cap
- $29.44B
- P/E
- 15.0x
- Volume
- 3.57M
- Fwd P/E
- 12.2x
- Beta
- 0.82
- Div yield
- 0.21%
- P/S
- 1.4x
- P/B
- 2.7x
- Profit margin
- +9.3%
- Op margin
- +15.0%
- ROE
- +19.4%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsSmart money
8 funds hold a position and insiders have been net buying.
What funds are doing
Activist stakes, short interest & more
Earnings
Earnings came in 1.9% above what analysts expected.
Earnings per share
$1.04 expected
Revenue
No comparable estimate
What the street expects next
EPS expected
$1.18 to $1.25
Revenue expected
16 analysts
Last 30 days
Analysts cutting estimates
Estimate drift
Change in 30 days
What the company said
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $5.14B | $4.67B | $5.13B | $5.29B |
| Cost of what it sold | $3.15B | $2.13B | $3.15B | $3.12B |
| Gross profit | $1.99B | $2.54B | $1.98B | $2.18B |
| What it spent | ||||
| Research and development | $292.0M | $362.0M | $345.0M | $323.0M |
| Sales and admin | $1.04B | $1.11B | $1.12B | $1.12B |
| Other operating costs | — | $403.0M | — | — |
| Total operating expenses | $1.34B | $1.88B | $1.46B | $1.44B |
| What was left | ||||
| Operating profit | $653.0M | $664.0M | $515.0M | $739.0M |
| Interest on debt | $123.0M | $103.0M | $96.0M | $114.0M |
| Profit before tax | $643.0M | $202.0M | $505.0M | $693.0M |
| Tax | $179.0M | $54.0M | $94.0M | $119.0M |
| Net profit | $446.0M | $184.0M | $389.0M | $573.0M |
| EBITDA | $902.0M | $865.0M | $755.0M | $953.0M |
Technicals
Price structure
This stock is under pressure, and looks oversold after a sharp drop.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage is bullish
Tone of tracked coverage
Jimenez Frank R Surrenders 3,131 Shares of GE HealthCare Technologies on September 1, 2026
NeutralSep 4Arduini Peter J Surrenders 11,515 Shares of GE HealthCare Technologies on September 1, 2026
NeutralSep 4GE HealthCare CEO Philip Rackliffe Withholds 798 Shares for RSU Tax Payment
NeutralSep 4GE HealthCare AIS CEO Philip Rackliffe Reports RSU Tax Withholding Share Disposals
NeutralSep 4Tucker Medical selects GE HealthCare MRI technology to advance personalized preventive care in Singapore
BullishSep 3SBC Medical to Participate in Several Upcoming Investor Conferences in September 2026
NeutralSep 3Mobile ECG Devices Market Outlook 2025-2035 Featuring Profiles AliveCor, Apple and iRhythm Technologies - Industry Forecast to Reach $9.03 Billion by 2035 as Remote Cardiac Monitoring Adoption Accelerates
BullishSep 2WORK Medical Technology Group LTD Ordinary Shares (NASDAQ: WOK) Stock Price, News & Analysis
NeutralSep 1
Macro
31 macro signals shaping GEHC right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results